Supriya Pharmaceuticals Limited

Supriya Pharmaceuticals Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U01100DL1985PLC445217 Incorporated 24 July 1985 ROC Delhi HQ New Delhi, Delhi, India
Active Public Limited Company pharma
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹9.64 Cr
Issued & subscribed
Open charges
₹3 Cr
Satisfied ₹7.94 Cr
Company age
41 yrs
Est. 1985
Directors on board
3
As per MCA filings
Active GSTINs
1
of 3 registered
Last financials
Mar 2025
Balance sheet date
Last AGM
04 Jun 2025
Annual general meeting

About Supriya Pharmaceuticals Limited

Data last updated:

Supriya Pharmaceuticals Limited is a public limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 July 1985 and has been in existence for over 41 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U01100DL1985PLC445217. Its GSTIN is 07AAFCS4958R2ZE (Delhi). The company holds 3 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹9.64 Cr. It is led by directors including Manish Gupta and Ramesh Dugar.

Its last annual general meeting (AGM) was held on 04 June 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 810 Arunachal Building, 19 Barkhamba Road Connaught Place, New Delhi, Delhi, India – 110001.

As per MCA filings, the company has open charges of ₹3 Cr and satisfied charges of ₹7.94 Cr on record. Court records list 18 cases involving the company, including 6 filed by the company and 12 filed against it; 2 cases are pending.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U01100DL1985PLC445217
Registration Number 445217
Incorporation Date 24 July 1985
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

CIN history

Supriya Pharmaceuticals has 3 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U01100DL1985PLC445217, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U01100DL1985PLC445217Current
U24232RJ1985PLC003363Previous
L24232RJ1985PLC003363Previous
U01100RJ1985PLC003363Previous

Contact details

Supriya Pharmaceuticals Limited's registered office is in New Delhi, Delhi.

  • Registered Address
    810 Arunachal Building, 19 Barkhamba Road Connaught Place, New Delhi, Delhi, India – 110001
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Supriya Pharmaceuticals Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Supriya Pharmaceuticals Limited

FY 2025 filings available

Financial Statement Summary

MetricsFY 2018-19FY 2017-18FY 2016-17FY 2015-16FY 2014-15
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA
Profit Before Tax
Tax Expense
Net Profit (PAT)
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2018-19FY 2017-18FY 2016-17FY 2015-16FY 2014-15
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Supriya Pharmaceuticals Limited, buy the company report.

Board of directors of Supriya Pharmaceuticals Limited

Supriya Pharmaceuticals has 3 current directors and 14 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Manish GuptaNominee Director06 Feb 20242 Years 9 MonthsCurrent
Ramesh DugarNominee Director08 Feb 201214 Years 9 MonthsCurrent
Yogesh KumarNominee Director16 May 20179 Years 6 MonthsCurrent

Charges & borrowings

Open charges
₹3 Cr
Satisfied charges
₹7.94 Cr
Breakdown by lending institutions
Canara Bank₹4.94 Cr
United Bank of India₹3.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
22 Aug 200590069297United Bank of India₹3 CrSatisfied
21 Jan 199890066760Canara Bank₹3 LakhSatisfied
20 Aug 199290067909Canara Bank₹3 CrSatisfied
31 Jan 199290066359Canara Bank₹30 LakhSatisfied
16 Aug 199190066351Canara Bank₹55 LakhSatisfied

To see the full charge records of Supriya Pharmaceuticals Limited, buy the company report.

Total charge records: 9 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Supriya Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Supriya Pharmaceuticals has 3 GST registrations: 1 active and 2 cancelled or inactive.

Total GSTINs
3
Active
1
Cancelled / inactive
2
GSTINStateStatusRegistered on
07AAFCS4958R2ZEDelhiActive27 Nov 2017

To see the full GST registrations and return filing status of Supriya Pharmaceuticals Limited, buy the company report.

Recent activity

Supriya Pharmaceuticals Limited has 17 board changes on record since 2007: 3 appointments and 14 cessations. The latest: Manish Gupta was appointed as Nominee Director on 06 Feb 2024.

Charges
A charge registered on 22 Aug 2005 via Charge ID 90069297 with United Bank Of India was fully satisfied on 23 Sep 2025.
AGM
Supriya Pharmaceuticals Limited last Annual general meeting of members was held on 04 Jun 2025 as per latest MCA records.
Filing
Supriya Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Manish Gupta was appointed as Nominee Director.
Ceased
Rajeev Dugar ceased to be Director.
Ceased
Ramesh Dugar ceased to be Director.
Ceased
Yatinder Nath Khemka ceased to be Director.
Ceased
Yogesh Kumar ceased to be Additional Director.
Ceased
Rakesh Kumar ceased to be Director.
Appointed
Yogesh Kumar was appointed as Nominee Director.
Ceased
Shobh Nath Shukla ceased to be Director.
Ceased
Chandrakure Parmeshwaram Madhu Kumar ceased to be Director.

28 earlier events are in the company report.

Frequently asked questions

Supriya Pharmaceuticals is an active public limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 July 1985 (41+ years old) and is registered under CIN U01100DL1985PLC445217.

Supriya Pharmaceuticals has 3 current directors:

The latest financial statements of Supriya Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 04 June 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Supriya Pharmaceuticals is 07AAFCS4958R2ZE, registered in Delhi. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.

The CIN (Corporate Identification Number) of Supriya Pharmaceuticals is U01100DL1985PLC445217. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Supriya Pharmaceuticals has 18 court cases on record: 6 filed by the company and 12 filed against it. 2 are pending. Most are in the high courts.

Supriya Pharmaceuticals was incorporated on 24 July 1985, making it 41+ years old. It is registered with the Registrar of Companies, Delhi.

Manish Gupta was appointed as Nominee Director on 06 Feb 2024. Rajeev Dugar ceased to be Director on 06 Feb 2024. Ramesh Dugar ceased to be Director on 05 Feb 2024. Supriya Pharmaceuticals has 17 board changes on record in total.

The registered office of Supriya Pharmaceuticals is at 810 Arunachal Building, 19 Barkhamba Road Connaught Place, New Delhi, Delhi, India – 110001.

Supriya Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.